Related articles
-
NewsUganda launches Phase I clinical study of Bundibugyo virus disease vaccine
A Phase I clinical study has been launched evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.
-
NewsKenya confirms first imported Bundibugyo virus disease case; WHO supports control efforts
Following the confirmation by Kenyan authorities of the country’s first imported case of Bundibugyo virus disease (BVD), the World Health Organization (WHO) is working closely with the Government of Kenya to intensify key control measures to prevent further spread of the virus.
-
NewsReading the ocean’s snowflakes: How AI decodes marine snow
A constant snowfall of tiny particles drifts through the ocean, carrying carbon, nutrients and plastic toward the deep sea. Scientists are now developing AI tools that could reveal what this “marine snow” is made of simply by analyzing underwater images.
More from News
-
NewsRapid genomic test identifies fungal bloodstream infections
Researchers have developed a rapid genomic method that can identify fungal bloodstream infections at the species level in about seven hours. By combining host DNA depletion, whole-genome amplification and real-time nanopore sequencing, the approach could help clinicians select appropriate antifungal treatment much earlier.
-
NewsOncolytic viruses and CAR cells team up against solid tumors
Oncolytic viruses and CAR-T or CAR-NK cells could be engineered together to overcome some of the biggest barriers in solid tumor treatment. A new review outlines how these therapies may be combined into programmable systems that improve tumor targeting, immune-cell infiltration and sustained antitumor activity.
-
NewsChiba University and Noguchi Memorial Institute for Medical Research partnership targets next-generation vaccines
Chiba University and the University of Ghana’s Noguchi Memorial Institute for Medical Research have launched a new research partnership aimed at advancing next-generation vaccines, therapeutics and diagnostics. The collaboration will connect expertise in Japan and Ghana to strengthen infectious disease research, researcher training and global health innovation.
No comments yet